Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
GIT1 and
GIT2
belong to the family of ADP-ribosylation factor GTPase-activating proteins (ARF-GAP) and have been implicated in the regulation of G protein-coupled receptor sequestration, cell migration, T-cell activation, neuronal spine formation, and aggregate formation in Huntington's disease. Examination of endogenous GIT protein expression in tissues, however, has been hampered by the lack of
GIT2
-specific antibodies. To visualize GIT1 and
GIT2
gene expression in mouse tissues, we created mice with
beta-galactosidase
(beta-Gal) reporters inserted into the two GIT genes. beta-Gal staining confirmed the broad tissue distribution of GIT1 and
GIT2
in the mouse but also revealed striking differences.
GIT2
is expressed in most cells of the body, whereas GIT1 is restricted to only a subset of cells. For example,
GIT2
is uniformly expressed throughout lung and liver, whereas GIT1 is restricted to cells lining blood vessels, bronchi, and bile ducts. Expression of GIT1 and
GIT2
is mutually exclusive in the testes, where a developmental expression shift occurs, with
GIT2
present in spermatogonia but GIT1 in mature spermatids. In conclusion, analysis of endogenous GIT expression revealed a nearly ubiquitous distribution of
GIT2
, whereas GIT1 is restricted to specific cell types even in tissues with apparently high GIT1 expression and is entirely absent from some tissues.
...
PMID:Differential expression of the ARF GAP genes GIT1 and GIT2 in mouse tissues. 1756 17